Nanoradio has Secured Financing of 12,5 M EUR, and Brings in 2 new Investors to Strengthen Nanoradio’s CompetitivenessKISTA, Sweden - Nanoradio today announced that they have signed an agreement with two new investors, Viking Venture and Creandum, who together with the current investors, Ferd Venture, Industrifonden, Innovacom, Nordic Venture Partners, Teknoinvest will fund Nanoradio through its growth phase. Samsung Announces First TCO Certified Netbook - Mercury Free, Ultra Energy-efficient and Ergonomically DesignedSTOCKHOLM - The Samsung N120 ultralight netbook is today announced as the first in the world to achieve the leading environmental and usability standard, TCO Certified. Free from mercury and other hazardous materials, offering outstanding energy efficiency and ergonomically designed keyboard and display - the N120 now adds the worlds toughest environmental and usability certifications - TCO Certified - to its list of features. ThromboGenics and BioInvent Start Recruitment of Second 100 Patient Cohort in Phase II DVT Prophylaxis Study With TB-402LEUVEN, Belgium and LUND, Sweden - ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402. This follows completion of recruitment of the first cohort of 100 patients ahead of schedule. TB-402 is a novel, long acting anticoagulant that is being developed for the prevention of deep vein thrombosis (DVT) following orthopaedic surgery. The decision to move ahead with the second cohort of this trial follows unanimous advice from the external efficacy and safety monitoring board to proceed using a higher dose of TB-402. Gyros Raises SEK 80 Million to Accelerate the Commercialization of its Gyrolab(R) Systems for the Cost-Efficient Development of BiopharmaceuticalsUPPSALA, Sweden - - Financing Led by SLS Invest Will Fund Gyros to Profitability Gyros AB, the leading provider of automated micro-immunoassays for therapeutic protein development, announces that it has raised SEK 80 million (approximately euro 7.5 million) in an equity fundraising led by SLS Invest, the Company’s leading shareholder. The new funds will enable Gyros to drive the further commercialization of its Gyrolab technology. This unique technology platform is rapidly gaining traction with leading pharma and biotech companies as well as CROs and CMOs focused on the efficient, accelerated development of new biopharmaceuticals. A growing list of more than 20 companies worldwide, including Merck, MedImmune, GSK, Amgen, Pfizer, Ablynx and ThromboGenics, currently benefit from Gyros’ unique Gyrolab systems, with an installed base of 40 systems. ABS Wins Order for Compressors for Treatment Plant in SwitzerlandMALMO, Sweden - ABS will be supplying compressors for one of the biggest treatment plants in Switzerland as of September 2009. The order is worth EUR 1.2 million. /C O R R E C T I O N — ABS Group/MALMO, Sweden - In the news release, “ABS Wins Order for Compressors for Treatment Plant in Switzerland” issued on 26 Jun 2009 06:45 GMT, by ABS Group over PR Newswire, we are advised by a representative of the company that the third paragraph containing the company information was missing, as incorrectly transmitted by PR Newswire. Complete, corrected release follows: Jolife AB Announces Launch of LUCAS(TM)2, the New Generation of LUCAS Chest Compression System, in Europe and CanadaLUND, Sweden - Now Electrically Powered, the Life-Saving Medical Device Offers the Most Lightweight and Compact Solution to Maintain Circulation in Cardiac Arrest Patients Ericsson Launches Stylish New Site SolutionSTOCKHOLM - Finding new locations for radio base stations is a growing challenge, especially in urban and suburban areas. Ericsson’s (NASDAQ:ERIC) new solution addresses this challenge by being as eye-catching, or as unobtrusive, as required in order to shorten the time to obtain building permission from authorities. The site is designed by renowned Scandinavian architect Thomas Sandell. PUMA(R) Golf Athlete Anna Nordqvist Wins McDonald’s LPGA ChampionshipBOSTON - Rookie Nordqvist Clinches First LPGA Major PUMA(R) Golf athlete and newcomer to the LPGA tour Anna Nordqvist won her first Major on Sunday at the McDonald’s LPGA Championship at the Bulle Rock Golf Course in Havre de Grace, Maryland. SportSpundit.com Fantasy World Twenty20 Steps Up to the WicketUPPSALA, Sweden - Fastest Growing Sports Community Launches Second Fantasy Cricket League: Fantasy World Twenty20 Mats Wilander Signs for Expekt.com as Tennis AmbassadorGZIRA, Malta - Former World No. 1 and seven-time Grand Slam winner Mats Wilander has signed as tennis ambassador for online gaming company Expekt.com. Roxette Reunion Special Hosted By Per Gessle to Air on Nordic Rox on SIRIUS XM’s The Spectrum ChannelNEW YORK - The Spectrum’s “Nordic Rox” weekly show to offer listeners a rare opportunity to hear live performances of Roxette’s biggest songs Dreampark Enters Croatia, Continuing Growth in Central and Eastern EuropeNORRKOPING, Sweden - Dreampark (www.dreampark.com), one of the leading IPTV middleware providers on the European market, today announced the delivery of its Dreamgallery(TM) middleware to the Croatian market with Croatian system integrator CS Computer Systems. The system was deployed for OiV, a Croatian state-owned nationwide broadcasting and channel aggregation organization. Beactica Announces Drug Discovery Agreement With Cubist PharmaceuticalsUPPSALA, Sweden - Beactica AB, the Swedish fragment-based drug discovery company, today announced that it has entered into an agreement with Cubist Pharmaceuticals, Inc. (Lexington, MA; NASDAQ: CBST). Under the agreement, Beactica will use its Sprint(TM) surface plasmon resonance (SPR)-integrated drug discovery platform to target multi-component proteins from pathogenic bacteria of interest to Cubist. Financial terms of the agreement were not disclosed. Ingate and Dialogic Team Up on Enterprise SIP Trunking SolutionSTOCKHOLM and PARSIPPANY, New Jersey - Interoperable Solution Enables Secure SIP Trunking for Legacy PBX and Contact Center Environments Ventelo Implements Ascade’s Routing & Trading SolutionSTOCKHOLM - Ventelo Awards Ascade With a Contract for the Interconnect Business Platform Carrier Cockpit(TM) - a Complete Solution for Routing & Trading New Nautiz eTicket(TM) Rugged PDA From Handheld Gives Public Transportation Advanced Electronic Ticketing CapabilitiesLIDKÖPING, Sweden - Handheld Today Announced the Nautiz eTicket(TM), a New Version of the Versatile Rugged Mobile Computer Nautiz X5(TM), Designed Especially for Transactions and Ticket Validations in the Public Transport Sector. Semcon - Development Partner for Concept Car in GermanyGOTEBORG, Sweden - A German automotive manufacturer has chosen Semcon as its development partner in a pilot study for a new concept car. The combined order for 2009 amounts to around SEK 50 million and the first phase of the project will run for the duration of the year. Successful Phase I/II Clinical Trial Results From Cancer Patients Treated With Anti-Cancer Drug From Axelar ABSTOCKHOLM - Axelar AB today announced successful completion of the single-day oral dosing part of its ongoing phase I/II clinical trial on cancer patients with its new anti-cancer drug AXL1717,an insulin-like growth factor-1 (IGF-1) receptor inhibitor which has no effects on the closely related insulin receptor. The study is conducted in Sweden on patients having terminal cancer disease. The results showed that a single-day dosing of AXL1717 could be successfully escalated with excellent tolerability. No dose-limiting toxicity was reported. The next part of the trial has now been approved, including a seven-day dosing BID regimen instead of single-day BID treatments. The first patients have already been treated with AXL1717 for seven days. Seattle’s Powerit Solutions Receives US$6 Million in Funding From Investors Including Siemens Venture Capital and ArcelorMittalSEATTLE - Growth of Intelligent Energy Management and Smart Grid Technology Powerit Solutions, a leading provider of intelligent energy management and efficiency systems to more than 2,500 companies worldwide, has announced US$6 million in new funding from Siemens Venture Capital and ArcelorMittal’s Clean Technology Fund, as well as from existing investors @Ventures and Expansion Capital Partners. The funding will be used to accelerate the company’s continuing growth into new industrial and commercial markets, solidify leadership in remote and on-site energy management, and continue product development efforts for key industrial vertical markets. Powerit’s Spara automated energy management system provides an intelligent facility-wide rules engine which leverages the flexibility of IP connectivity and the economy of wireless devices to address critical emerging issues such as smart grid management, real-time pricing, and automated demand response. Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)STOCKHOLM, Sweden - Results to be Presented at World Congress of Nephrology 2009 Pharmalink AB announced today that it has completed its open Phase II trial evaluating the efficacy and safety of Nefecon(R) in IgA nephropathy, a glomerulonephritis leading to end-stage renal disease. Nefecon is an enteric formulation of a locally acting corticosteroid which downregulates the inflammatory process in the kidneys through suppression of the gut immune system. Cellectricon and BioFocus DPI Advance High Throughput ion Channel Drug DiscoveryGOTHENBURG, Sweden - Cellectricon, a leading provider of automated screening solutions for drug discovery, today announced its collaboration with BioFocus DPI, a contract research organization with leading expertise in ion channel screening. BioFocus DPI will utilize Cellectricon’s Dynaflow(R)HT, a fully automated patch clamp (APC) system, to further increase its electrophysiology-based screening capacity, particularly for fast ligand-gated ion channels. Jabra Ushers in a New Dawn in Mobile Music Headsets With the Jabra HaloCOPENHAGEN - Enjoy Crystal-Clear Sounds From any Bluetooth-Enabled* or Corded Music Playing Device With one Great Looking Headset Pharmalink AB Strengthens its Board of Directors and Signals a Strategic Step Towards Late Phase Product DevelopmentSTOCKHOLM - Pharmalink AB today announced that it has strengthened its Board of Directors as the company’s portfolio continues to move towards late stage product development and commercialization. Two highly experienced pharmaceutical and biotechnology advisors, Anders Wiklund and Jens Christensen, are joining the Board. In addition, Lennart Hansson, Director of the lifesciences business area at Industrifonden joins the Board as the Industrifonden representative. Students of St. Petersburg State University of IT, Mechanics and Optics Crowned World Champions of the IBM-sponsored ‘Battle of the Brains’STOCKHOLM - Award Ceremony at Stockholm Concert Hall Where the Nobel Prizes Are Presented Students from St. Petersburg State University of IT, Mechanics and Optics are crowned the 2009 ACM (ACM) (www.acm.org/) International Collegiate Programming Contest (ICPC) (icpc.baylor.edu/) World Champions in the Stockholm Concert Hall where the Nobel Prizes are presented every year. Sponsored by IBM (NYSE: IBM), the competition took place today at KTH, the Royal Institute of Technology (KTH) (www.kth.se/). DfR Solutions Chosen to Develop Software Solution for Integrated Circuit WearoutCOLLEGE PARK, Maryland - Consequences of Moore’s Law Creates Major Concerns for Government Agencies and Critical Need in the Electronics Industry SportsPundit.com Aims for Big Hitters in its First Online Fantasy Cricket TournamentSTOCKHOLM - SportsPundit.com expects to attract big hitters to play its first online Fantasy Cricket tournament based on the Indian Premier League (IPL) 2009 season. Oasmia: FDA Grants Paclical(R) Orphan Drug Designation for Ovarian Cancer in the USAUPPSALA, Sweden - Oasmia Pharmaceutical, Uppsala, Sweden, has been granted Orphan Drug designation by the USA FDA of Paclical(R) for the treatment of ovarian cancer. Orphan Drug designation can entail additional assistance from FDA to expedite and optimize drug development and upon approval a seven year market exclusivity is granted. Rebtel Introduces World’s Lowest Rates on Calls to NigeriaSTOCKHOLM - First 30 Minutes Free to New Subscribers Rebtel, the people’s global communications company, today slashed in half its rates to Nigeria so Nigerians living abroad can call their loved ones at home for just 9.9 cents per minute. Konftel 300IP Now Rated “Avaya Compliant”UMEÅ, Sweden - Konftel 300IP - an SIP Based Conference Phone is Compatible With CareerBuilder.se Offers Tips on Making Yourself Recession-Proof at Work and Finding a Job After a LayoffSTOCKHOLM - Uncertainty around today’s economy has left some workers feeling uneasy Dreampark Replaces IPTV Middleware Competitor at Ireland’s Magnet NetworksNORRKOPING, Sweden - Dreampark, one of the leading IPTV middleware providers on the European The Astellas European Foundation Announces Winner of the 2009 Urology Prize FundSTAINES, England - On Thursday 19th March 2009, at a ceremony held at the 24th annual EAU Dreampark Boosts IPTV User Experience With Improved SVG Client for MiddlewareNORRKOPING, Sweden - Dreampark, one of the leading IPTV middleware providers on the European Hansoft Launches Version 5.3 at GDCUPPSALA, Sweden - Hansoft, the leading vendor of tools for project management and QA in the |
